Search - tctmd.com

Displaying 181 - 200 of 617

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Practical Strategies to Foster Diversity in Cardiology Clinical Trials

Caitlin E. Cox

October 22, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

APPRAISE ATP Highlights the Trade-offs of Antitachycardia Pacing

Todd Neale

October 09, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Daily News

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

Todd Neale

October 02, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

Advertisement

October 2024 Dispatch for the CV Team

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Practical Strategies to Foster Diversity in Cardiology Clinical Trials

What’s Going to Be Big at TCT 2024?

AI-Based CT Can Accurately Screen Patients for TMVR

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

AHA Statement Outlines Cardiac Contributions to Brain Health

MACE in CV Trials: Has the Outcome Outlived Its Role?

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Will Semaglutide Change Cardiac Surgery? It Already Has

APPRAISE ATP Highlights the Trade-offs of Antitachycardia Pacing

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

FDA Approves First New PET Imaging Tracer for Cardiac Testing in Decades

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content